Skip to content

Medpace Voice

Tag: Oncology

Clinical Development

Oncology Breakthroughs – ASCO 2024 Highlights

  • June 13, 2024

Explore insights from Medpace oncology experts as they identify several of the latest innovations in hematologic and oncologic research shared at ASCO 2024.

Clinical Development

Medpace Expands Oncology Medical Leadership Team

  • March 19, 2024

Medpace is pleased to announce the addition of new Oncology expert, Dr. Amanda Goldrick, to the Medical Leadership team.

Clinical Development

Emerging Trends in Hematology – ASH 2023 Highlights

  • December 18, 2023

In December 2023, Medpace classic and malignant hematology experts attended the 65th American Hematology Society (ASH) conference in San Diego, CA. Learn more from Blythe…

Company Spotlight

Breast Cancer Awareness Month

  • October 30, 2023

[New Webinar] In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women…

Company Spotlight

Medpace Strengthens Women’s Health Team

  • November 16, 2022

Medpace is pleased to announce that Dr. Aparna Shah has joined Medpace's Women's Health medical leadership team. With her addition, Medpace can offer Sponsors even…

Central Laboratories

[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges

  • August 16, 2022

Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…

Company Spotlight

Medpace Welcomes Dr. DeWire-Schottmiller to the Hematology/Oncology Team

  • April 28, 2021

Dr. Mariko DeWire-Schottmiller is a board-certified pediatric hematologist/oncologist with 15 years of experience in clinical research, academia, and clinical oncology practice in Oncology and Neuro-oncology.…

Clinical Development

The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals

  • August 6, 2020

In a new article, experts from Medpace’s radiation oncology, imaging, regulatory, and operational teams discuss the growing space of radiopharmaceutical development.

Company Spotlight

Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective

  • April 24, 2020

Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety…

Core Imaging Laboratory

Medpace Core Laboratories is Pleased to Announce A Successfully Completed Inspection by the FDA

  • April 7, 2020

Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or…